Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL; Alliance for Clinical Trials in Oncology. Smith EM, et al. Among authors: bressler lr. JAMA. 2013 Apr 3;309(13):1359-67. doi: 10.1001/jama.2013.2813. JAMA. 2013. PMID: 23549581 Free PMC article. Clinical Trial.
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
Smith EM, Pang H, Ye C, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Le-Lindqwister N, Fadul CE, Loprinzi C, Shapiro CL; Alliance for Clinical Trials in Oncology. Smith EM, et al. Among authors: bressler lr. Eur J Cancer Care (Engl). 2017 Mar;26(2):10.1111/ecc.12421. doi: 10.1111/ecc.12421. Epub 2015 Nov 25. Eur J Cancer Care (Engl). 2017. PMID: 26603828 Free PMC article.
Temozolomide in malignant gliomas: current use and future targets.
Villano JL, Seery TE, Bressler LR. Villano JL, et al. Among authors: bressler lr. Cancer Chemother Pharmacol. 2009 Sep;64(4):647-55. doi: 10.1007/s00280-009-1050-5. Epub 2009 Jun 19. Cancer Chemother Pharmacol. 2009. PMID: 19543728 Review.
Going past the data for temozolomide.
Villano JL, Letarte N, Bressler LR. Villano JL, et al. Among authors: bressler lr. Cancer Chemother Pharmacol. 2012 Apr;69(4):1113-5. doi: 10.1007/s00280-011-1796-4. Epub 2011 Dec 7. Cancer Chemother Pharmacol. 2012. PMID: 22147076 Clinical Trial.
Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study.
Lulla RR, Goldman S, Yamada T, Beattie CW, Bressler L, Pacini M, Pollack IF, Fisher PG, Packer RJ, Dunkel IJ, Dhall G, Wu S, Onar A, Boyett JM, Fouladi M. Lulla RR, et al. Neuro Oncol. 2016 Sep;18(9):1319-25. doi: 10.1093/neuonc/now047. Epub 2016 Mar 28. Neuro Oncol. 2016. PMID: 27022131 Free PMC article. Clinical Trial.
Hematologic adverse events associated with temozolomide.
Villano JL, Letarte N, Yu JM, Abdur S, Bressler LR. Villano JL, et al. Among authors: bressler lr. Cancer Chemother Pharmacol. 2012 Jan;69(1):107-13. doi: 10.1007/s00280-011-1679-8. Epub 2011 May 26. Cancer Chemother Pharmacol. 2012. PMID: 21614470
Cyclophosphamide-induced facial discomfort.
Kosirog-Glowacki JL, Bressler LR. Kosirog-Glowacki JL, et al. Among authors: bressler lr. Ann Pharmacother. 1994 Feb;28(2):197-9. doi: 10.1177/106002809402800208. Ann Pharmacother. 1994. PMID: 8173133
30 results